- Home
- ACAD vs SHAK Comparison
ACAD vs SHAK Comparison
Compare ACAD & SHAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- SHAK
- Stock Information
- Founded
- ACAD 1993
- SHAK 2004
- Country
- ACAD United States
- SHAK United States
- Employees
- ACAD N/A
- SHAK N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- SHAK Restaurants
- Sector
- ACAD Health Care
- SHAK Consumer Discretionary
- Exchange
- ACAD Nasdaq
- SHAK Nasdaq
- Market Cap
- ACAD 2.8B
- SHAK 3.1B
- IPO Year
- ACAD 2004
- SHAK 2015
- Fundamental
- Price
- ACAD $14.73
- SHAK $83.22
- Analyst Decision
- ACAD Buy
- SHAK Buy
- Analyst Count
- ACAD 16
- SHAK 18
- Target Price
- ACAD $23.93
- SHAK $122.28
- AVG Volume (30 Days)
- ACAD 1.8M
- SHAK 1.4M
- Earning Date
- ACAD 05-07-2025
- SHAK 05-01-2025
- Dividend Yield
- ACAD N/A
- SHAK N/A
- EPS Growth
- ACAD N/A
- SHAK N/A
- EPS
- ACAD 1.36
- SHAK 0.24
- Revenue
- ACAD $957,797,000.00
- SHAK $1,252,608,000.00
- Revenue This Year
- ACAD $13.07
- SHAK $19.19
- Revenue Next Year
- ACAD $9.88
- SHAK $12.99
- P/E Ratio
- ACAD $10.83
- SHAK $346.78
- Revenue Growth
- ACAD 31.85
- SHAK 15.18
- 52 Week Low
- ACAD $13.40
- SHAK $72.93
- 52 Week High
- ACAD $20.68
- SHAK $139.89
- Technical
- Relative Strength Index (RSI)
- ACAD 38.07
- SHAK 44.24
- Support Level
- ACAD $14.34
- SHAK $78.90
- Resistance Level
- ACAD $15.18
- SHAK $85.55
- Average True Range (ATR)
- ACAD 0.80
- SHAK 6.25
- MACD
- ACAD -0.02
- SHAK 0.41
- Stochastic Oscillator
- ACAD 38.22
- SHAK 42.21
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.
About SHAK Shake Shack Inc.
Shake Shack Inc is a roadside burger stand. It is serving a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water.